Epidermal Growth Factor Receptor Exon 20 Insertion in Early Resected Non-Small Cell Lung Cancer: A Retrospective, Single-Center Study in Taiwan
<i>EGFR</i> exon 20 insertions do not significantly shorten DFS, but are associated with inferior OS in early-stage resected NSCLC. Given the limited treatment options, the role of adjuvant therapy warrants further investigation.
Authors
- Yen‐Shou Kuo (ORCID: https://orcid.org/0000-0002-4948-5219)
- Ying‐Yi Chen (ORCID: https://orcid.org/0000-0003-3753-4877)
- Tsai-Wang Huang (ORCID: https://orcid.org/0000-0001-8741-9223)
- Hsu‐Kai Huang (ORCID: https://orcid.org/0000-0002-4358-4822)
- Ying Shian Chen
- C.-Y. Lin
- Kuan Hsun Lin (ORCID: https://orcid.org/0000-0002-3371-5489)
Institutions
- Kaohsiung Armed Forces General Hospital (TW)
- Taichung Armed Forces General Hospital (TW)
- National Defense Medical Center (TW)
Publication Details
- Journal
- Journal of Chest Surgery
- Published
- 2025-08-25
- DOI
- https://doi.org/10.5090/jcs.25.027
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00